image

17-21 October 2025

European Society for Medical Oncology​ International Conference® (ESMO 2025) Berlin, German​y

The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.

Novocure Presentation Schedule​

Sunday, October 19

09:00 - 09:45 (Etc/UTC)

Poster

Phase 3 study of TTFields in locally advanced pancreatic adenocarcinoma (PANOVA-3): post-hoc subgroup analyses based on device usage and CA 19-9

Chair(s): Hani Babiker

Abstract

Sunday, October 19

09:00 - 09:45 (Etc/UTC)

Poster

Phase I Study of Tumor Treating Fields (TTFs) with Cabozantinib or with Nab-Paclitaxel and Pembrolizumab in Patients with Advanced Solid Tumors Involving the Abdomen or Thorax

Chair(s): Apostolia Maria Tsimberidou

Sunday, October 19

09:00 - 09:45 (Etc/UTC)

Poster

Phase I Study of NovoTTF-100L(P) in Combination with Chemotherapy in Patients with Predominant Hepatic Metastatic Colorectal Cancer

Chair(s): Siqing Fu

Sunday, October 19

09:00 - 09:45 (Etc/UTC)

E-Poster

TTFields Disrupt Prothrombotic Signaling in Glioblastoma Cells and Blood

Chair(s): Thomas Freitag

Novocure Websites

This website is intended for people seeking information on Novocure’s worldwide business.



Novocure logo

All rights reserved.

MyLink, MyNovocure, Novocure, and Optune Gio are trademarks of Novocure GmbH.

All other trademarks, registered or unregistered, are the property of their respective owners.

MED-GL-PAN-2400032